Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury

被引:20
|
作者
Mueller, Alison L.
Hryshko, Larry V.
Dhalla, Naranjan S.
机构
[1] Univ Manitoba, St Boniface Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada
[2] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R2H 2A6, Canada
基金
加拿大健康研究院;
关键词
Ischemic heart disease; Subcellular organelles; Extracellular matrix; Metalloproteinases; Cathepsin; Calpain; SARCOPLASMIC-RETICULUM FUNCTION; CONVERTING ENZYME-INHIBITORS; PERFUSED RAT-HEART; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; MATRIX-METALLOPROTEINASE ACTIVITY; AMINOPEPTIDASE-P INHIBITOR; OXIDATIVE STRESS INJURY; NA+-K+-ATPASE; INFARCT SIZE; CALPAIN ACTIVATION;
D O I
10.1016/j.ijcard.2012.01.103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Various procedures such as angioplasty, thrombolytic therapy, coronary bypass surgery, and cardiac transplantation are invariably associated with ischemia-reperfusion (I/R) injury. Impaired recovery of cardiac function due to I/R injury is considered to be a consequence of the occurrence of both oxidative stress and intracellular Ca2+-overload in the myocardium. These changes in the ischemic myocardium appear to activate both extracellular and intracellular proteases which are responsible for the cleavage of extracellular matrix and subcellular structures involved in the maintenance of cardiac function. It is thus intended to discuss the actions of I/R injury on several proteases, with a focus on calpain, matrix metalloproteinases, and cathepsins as well as their role in inducing alterations both inside and outside the cardiomyocytes. In addition, modifications of subcellular organelles such as myofibrils, sarcoplasmic reticulum and sarcolemma as well as extracellular matrix, and the potential regulatory effects of endogenous inhibitors on protease activities are identified. Both extracellular and intracellular proteolytic activities appear to be imperative in determining the true extent of I/R injury and their inhibition seems to be of critical importance for improving the recovery of cardiac function. Thus, both extracellular and intracellular proteases may serve as potential targets for the development of cardioprotective interventions for reducing damage to the heart and retarding the development of contractile dysfunction caused by I/R injury. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [41] MITOCHONDRIAL DYSFUNCTION IN ISCHEMIA-REPERFUSION
    SARIS, NEL
    ERIKSSON, KO
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 : 171 - 176
  • [42] Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion
    Shields, CJ
    Winter, DC
    Manning, BJ
    Wang, JH
    Kirwan, WO
    Redmond, HP
    ARCHIVES OF SURGERY, 2003, 138 (01) : 9 - 14
  • [43] ROLE OF CAMP IN LUNG INJURY DUE TO ISCHEMIA-REPERFUSION (IR)
    SEIBERT, AF
    TAYLOR, A
    HAYNES, J
    FASEB JOURNAL, 1991, 5 (06): : A1723 - A1723
  • [44] CORONARY VASCULAR INJURY DUE TO ISCHEMIA-REPERFUSION IS REDUCED BY PENTOXIFYLLINE
    DAUBER, IM
    LESNEFSKY, EJ
    ASHMORE, RC
    MARTEL, DM
    SHERIDAN, FM
    WEIL, JV
    HORWITZ, LD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (03): : 1250 - 1256
  • [45] Mechanisms of cellular alterations due to ischemia-reperfusion injury in the heart
    Temsah, RM
    Netticadan, T
    Dhalla, NS
    MYOCARDIAL ISCHEMIA AND PRECONDITIONING, 2003, 6 : 149 - 164
  • [46] Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo
    Hiran A. Prag
    Laura Pala
    Duvaraka Kula-Alwar
    John F. Mulvey
    Du Luping
    Timothy E. Beach
    Lee M. Booty
    Andrew R. Hall
    Angela Logan
    Volha Sauchanka
    Stuart T. Caldwell
    Ellen L. Robb
    Andrew M. James
    Zhelong Xu
    Kourosh Saeb-Parsy
    Richard C. Hartley
    Michael P. Murphy
    Thomas Krieg
    Cardiovascular Drugs and Therapy, 2022, 36 : 1 - 13
  • [47] Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo
    Prag, Hiran A.
    Pala, Laura
    Kula-Alwar, Duvaraka
    Mulvey, John F.
    Du, Luping
    Beach, Timothy E.
    Booty, Lee M.
    Hall, Andrew R.
    Logan, Angela
    Sauchanka, Volha
    Caldwell, Stuart T.
    Robb, Ellen L.
    James, Andrew M.
    Xu, Zhelong
    Saeb-Parsy, Kourosh
    Hartley, Richard C.
    Murphy, Michael P.
    Krieg, Thomas
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (01) : 1 - 13
  • [48] Intracellular Signaling MAPK Pathway After Cerebral Ischemia-Reperfusion Injury
    Kovalska, Maria
    Kovalska, Libusa
    Pavlikova, Martina
    Janickova, Maria
    Mikuskova, Katarina
    Adamkov, Marian
    Kaplan, Peter
    Tatarkova, Zuzana
    Lehotsky, Jan
    NEUROCHEMICAL RESEARCH, 2012, 37 (07) : 1568 - 1577
  • [49] Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes
    Wu, Qibiao
    Li, Haitao
    Wu, Ye
    Shen, Weixing
    Zeng, Li
    Cheng, Haibo
    He, Ling
    JOURNAL OF ETHNOPHARMACOLOGY, 2011, 138 (01) : 34 - 39
  • [50] Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
    Tanajak, Pongpan
    Sa-nguanmoo, Piangkwan
    Sivasinprasasn, Sivaporn
    Thummasorn, Savitree
    Siri-Angkul, Natthaphat
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    JOURNAL OF ENDOCRINOLOGY, 2018, 236 (02) : 69 - 84